NLRP3 and Hepatic fibrosis: The altered structure of gut microbiota in the CCl4 group and NLRP3−/−+CCl4 mice suggested that NLRP3 might exert its pro-inflammatory role via altering the activity of signaling pathways and ECs in the gut microbiota to facilitate the development of liver fibrosis.